Manoj Mittal, MD
Gastroenterology · Easton, PANPI 1720172737
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $232 of the $262 with a category attached, or 88.4%. 5 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 47.7% of the total. Reporting peaked in 2021 at $125 and has fallen 75.7% since, to $30 in 2024. That places this record below the midpoint for gastroenterology clinicians in PA, where the typical reported total is $1,806.
Across 7 payments — averaging $37.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$125
- Johnson & Johnson$44
- Biofire Diagnostics, LLC$40
- Pfizer$30
- Takeda Pharmaceuticals U.S.A., Inc.$22
What the payments were for
- Food & beverage$23288%
- Education$3012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Johnson & Johnson | 3 | $44 |
| Biofire Diagnostics, LLC | 1 | $40 |
| Pfizer | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPOSIA$125
How this compares
$262 in reported general payments places this provider in the 20th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 15 | $13,436 |
| Dexlansoprazole DrDexlansoprazole | 14 | $6,956 |
| Ursodiol | 20 | $3,487 |
| Pantoprazole Sodium | 235 | $3,045 |
| Esomeprazole Magnesium | 56 | $1,555 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 86 | $1,406 |
| Omeprazole | 85 | $1,404 |
| Colestipol Hcl | 13 | $737 |
| Famotidine | 63 | $598 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 19 | $442 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 28 | $407 |
| Dicyclomine Hcl | 31 | $362 |
| Sucralfate | 11 | $263 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Easton
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Elie AounPittsburgh$323K
- Andrew TinsleyHershey$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.